Gates Foundation Spends $ 120 Million to Access COVID-19 Pills | WGN Radio 720

File – This May 5, 2019 file photo shows Bill Gates, co-founder of Microsoft in Omaha, Nebraska. Country if the drug is approved by a regulatory agency. In a statement released Wednesday, October 20, 2021, the Private Foundation did not decide how to allocate the funds, but the funds were “various needed to develop and manufacture generic versions.” It will be used to “support activities.” , Molnupiravir. (AP Photo / Nati Harnik, file)

Bill & Melinda Gates Foundation spends $ 120 million to promote access to generic versions of Merck’s antiviral COVID-19 pill for low-income countries if the drug is approved by regulatory agencies It states.

The private foundation has not decided how to allocate the funds in a statement released Wednesday, but will use the funds to “support the various activities needed to develop and manufacture generic versions.” Said.

Merck licenses its technology to generic drug manufacturers in India. Under the agreement, the company announced that it will provide manufacturers with licenses to supply medicines to India and more than 100 other low- and middle-income countries. It is unknown how many generic drugs can be used.

The Gates Foundation also states that its funding is also intended to assist in the preparation of regulations, deliveries, and other routes to make pills more accessible when they become available. increase.

The Food and Drug Administration has not approved the pill, and outside experts will meet on November 30 to scrutinize the drug. If approved by the regulatory agency, this drug will be the first tablet available for the treatment of COVID-19.

Trevor Munder, president of the Foundation’s Global Health Program, believes that generic manufacturers will not increase production unless they know they are in demand and are likely to wait until next year to start production.

“We don’t want to wait for them,” he said. “So this money is about activating them now.”

Merck and its partner, Ridgeback Biotherapeutics, said early results on pills showed that high-risk patients who received pills within 5 days of COVID-19 symptoms had about half the rate of hospitalization and death. increase.

The Gates Foundation’s Mandel states that the study needs to be replicated in other countries, so officials there can be more familiar with the drug. “Otherwise, healthcare professionals and doctors don’t have the demands that are immediately acceptable like elsewhere,” he said.

Funding is provided as many countries struggle to secure access to the COVID-19 vaccine.

Lawrence Gostin, a professor of global health law at Georgetown University, says it’s good that more is being done to support manufacturing abroad, but more difficulties will arise in the future. It states that there is a possibility. “This is limited to India only,” he said. “Therefore, their ability to launch production fast enough to supply low- and middle-income countries will be a huge challenge.”


The Associated Press is supported by Lily Donations for charitable and non-profit coverage. AP is solely responsible for all content. For all coverage of AP’s philanthropy, please visit

Gates Foundation Spends $ 120 Million to Access COVID-19 Pills | WGN Radio 720

Source link Gates Foundation Spends $ 120 Million to Access COVID-19 Pills | WGN Radio 720

Related Articles

Back to top button